Laura Suhadolnik Maxon

Laura will help commercialize SLIM technology in markets where it will propel science for enhancing disease diagnosis, treatment, and prevention. Laura’s experience in mass spectrometry sales, product management, and strategy development at GlaxoSmithKline and Waters Corporation, along with her Biomedical Engineering degree from Drexel University, have given her the skill set to not only understand the technology, but also to identify in which applications it will have the highest impact for our customers.